- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
12
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
12 companies
Lee's Pharmaceutical Holdings
Market Cap: HK$953.9m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.62
7D
-4.1%
1Y
16.5%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.23
7D
-0.4%
1Y
58.2%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$10.8b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$27.00
7D
-12.8%
1Y
264.9%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.68
7D
-3.2%
1Y
34.0%
Medtide
Market Cap: HK$4.0b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$28.00
7D
1.4%
1Y
n/a
Essex Bio-Technology
Market Cap: HK$2.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.95
7D
-3.2%
1Y
36.2%
Viva Biotech Holdings
Market Cap: HK$4.0b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.89
7D
-8.3%
1Y
103.2%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.27
7D
2.4%
1Y
51.2%
HBM Holdings
Market Cap: HK$11.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$13.36
7D
-2.8%
1Y
1,022.7%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.66
7D
-3.3%
1Y
1.5%
Alphamab Oncology
Market Cap: HK$10.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$10.60
7D
-2.0%
1Y
186.5%
Consun Pharmaceutical Group
Market Cap: HK$12.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.00
7D
1.4%
1Y
89.2%